Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation and SLC30A8 Polymorphism in T2DM
NCT03112382Phase 4Completed
- Sponsor
- Cairo University
- Start
- Nov 2015
- Primary completion
- May 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Cairo University. Primary endpoints: SLC30A8 rs13266634 polymorphism at 1 year and Serum zinc level. Started Nov 2015; status: completed.
Beyond the preview
Go deeper on NCT03112382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112382.